COVID and SARS News
June 15, 2024
Top Headlines
May 24, 2024 Researchers discovered that people who experienced symptomatic breakthrough infections develop T cells that are better at recognizing and targeting SARS-CoV-2, including the Omicron and Delta variants. The researchers describe this increased ...
May 17, 2024 A study has found that repeat vaccination with updated versions of the COVID-19 vaccine promotes the development of antibodies that neutralize a wide range of variants of the virus that causes ...
May 6, 2024 Researchers have developed a new vaccine technology that has been shown in mice to provide protection against a broad range of coronaviruses with potential for future disease outbreaks -- including ones we don't even know ...
Apr. 1, 2024 Researchers have developed a new vaccine that offers broad protection against not only SARS-CoV-2 variants, but also other bat sarbecoviruses. The groundbreaking trivalent vaccine has shown complete protection with no trace of virus in the lungs, ...
Latest Headlines
updated 6:13pm EDT
May 30, 2024 A new human monoclonal antibody moves a step closer to a universal antibody cocktail that works against all strains of ...
June 10, 2024 A new study suggests that the immune response of lung endothelial cells, which line the blood vessels, is too low during the early stage of COVID-19 ...
May 22, 2024 Researchers conducted a Phase III trial to test the 100-year-old Bacillus Calmette-Gu rin (BCG) vaccine in people with type 1 diabetes during the COVID-19 ...
Apr. 3, 2024 To better understand COVID-19's spread during the pandemic, public health officials expanded wastewater surveillance. These efforts track SARS-CoV-2 ...
Mar. 8, 2024 COVID-19 vaccines elicit strong T-cell responses, but clonal-resolution analyses of these responses have not previously been performed. To address ...
Feb. 14, 2024 Women who receive an mRNA-based COVID-19 vaccination or booster during pregnancy can provide their infants with strong protection against symptomatic ...
Jan. 26, 2024 Scientists have found direct evidence that exposure to common cold coronaviruses can train T cells to fight SARS-CoV-2. The research promises to help scientists design and improve 'pan-coronavirus' ...
Jan. 17, 2024 Imagine a vaccine that speeds up the production of antibodies against SARS-CoV-2, the virus that spreads COVID-19. A research team has developed such ...
Jan. 11, 2024 A new study suggests that once developed, a universal vaccine in advance of the next coronavirus epidemic/pandemic can save up to 7 million ...
Jan. 8, 2024 New research shows that the recently emerged BA.2.86 omicron subvariant of the virus that causes COVID-19 can be neutralized by bivalent mRNA ...
Earlier Headlines
Dec. 4, 2023 New research shows being overweight can impair the body's antibody response to SARS-CoV-2 infection but not to the protection offered by ...
Nov. 6, 2023 Researchers have developed a nasal spray vaccine that delivers the SARS-CoV-2 spike protein into cells of the airway, stopping viral particle replication before a virus can enter the bloodstream. ...
Oct. 26, 2023 Researchers demonstrate a nanopore-based technique that can detect different variants of SARS-CoV-2, the virus that causes COVID-19. The method was very effective in detecting the Omicron variant of ...
Oct. 18, 2023 A vaccine designed to protect against three different deadly coronaviruses shows success in mouse studies, demonstrating the viability of a pan-coronavirus vaccine developed by researchers at the ...
Oct. 2, 2023 In September 2022, new bivalent COVID-19 boosters became available in the United States, but less than 20% of the eligible population ultimately received one. A new study identified why so many ...
Oct. 2, 2023 Altered measles and mumps viruses could be used as a platform to create a trivalent COVID-19 vaccine that triggers immunity to multiple variant strains of the SARS-CoV-2 virus, new research in ...
Aug. 11, 2023 Receiving a COVID-19 mRNA vaccine or booster during pregnancy can benefit pregnant people and their newborn infants, according to new ...
Mar. 9, 2023 Researchers have examined how patient characteristics and COVID-19 infection may affect the antibody responses of people with HIV -- including responses against SARS-CoV-2 proteins as well as ...
Dec. 22, 2022 Researchers have demonstrated that people suffering from blood cancer have a good immune response to COVID-19 vaccinations. Vaccination protects patients with B-cell lymphoma and multiple myeloma ...
First-Line Immune Defenses Against COVID-19 Are Short-Lived and May Explain Reinfection, Study Shows
Dec. 20, 2022 A new study finds that antibodies produced in the nose decline nine months after COVID-19 infection, while antibodies found in the blood last at least a ...
Dec. 13, 2022 The long-term immune response to SARS-CoV-2 mRNA vaccination was similar in pregnant individuals compared with non-pregnant individuals of reproductive age, according to a new study. The similarity ...
Dec. 13, 2022 Adult hospitalizations from Omicron-related SARS-CoV-2 (COVID-19) were less severe than Delta, and the Pfizer-BioNTech vaccine (also known as Comirnaty and BNT162b2) remains effective in preventing ...
Dec. 9, 2022 Researchers have developed novel compounds with the potential to be drug treatments for the SARS-CoV-2 virus, responsible for the COVID-19 pandemic. This work also proves that replacing easily ...
Dec. 7, 2022 In a study adding to the pool of knowledge about viral entry, researchers have published a highly compelling study showing a previously unrecognized entryway for SARS-CoV-2, the virus that causes ...
Dec. 6, 2022 People who receive monoclonal antibodies before vaccines may benefit from increased coverage, due to antibody feedback inhibition, according to new ...
Dec. 6, 2022 Researchers studied antibody-mediated neutralization of SARS-CoV-2 variants following a fourth vaccination with different vaccine boosters. Their results showed that booster vaccination improved ...
Dec. 1, 2022 mRNA COVID-19 vaccines are less effective against Omicron infections than other variants. A study suggests that the additional protection offered by the initial booster shot may be reduced among ...
Dec. 1, 2022 Immune T cells are continuing to target the spike protein of SARS-CoV-2 variants of concern, although mutations are making some T cells less effective, according to new ...
Nov. 25, 2022 An experimental mRNA-based vaccine against all 20 known subtypes of influenza virus provided broad protection from otherwise lethal flu strains in initial tests, and thus might serve one day as a ...
Nov. 23, 2022 Are the currently approved antibody therapies used to treat individuals at increased risk for severe COVID-19 disease also effective against currently circulating viral variants? A recent study shows ...
Monday, December 4, 2023
Monday, November 6, 2023
Thursday, October 26, 2023
Wednesday, October 18, 2023
Monday, October 2, 2023
- Study Uncovers Reasons Americans Did Not Get Booster Vaccines
- Trivalent Vaccine Candidate Fights Measles, Mumps, SARS-CoV-2
Friday, August 11, 2023
Thursday, March 9, 2023
Thursday, December 22, 2022
Tuesday, December 20, 2022
- First-Line Immune Defenses Against COVID-19 Are Short-Lived and May Explain Reinfection, Study Shows
Tuesday, December 13, 2022
- Long-Term Immune Response to SARS-CoV-2 mRNA Vaccination Is Unaffected by Pregnancy, Study Finds
- Studies Find Omicron Related Hospitalizations Lower in Severity Than Delta, and Pfizer-BioNTech COVID Vaccine Remains Effective in Preventing Hospitalizations
Friday, December 9, 2022
Wednesday, December 7, 2022
Tuesday, December 6, 2022
Thursday, December 1, 2022
- Primary Series and Original Booster Provide Protection Against Omicron Infection
- Immune T Cell Defense Is Coping With COVID-19 Variants of Concern -- For Now
Friday, November 25, 2022
Wednesday, November 23, 2022
Tuesday, November 22, 2022
Thursday, November 10, 2022
Wednesday, November 9, 2022
Friday, November 4, 2022
Wednesday, November 2, 2022
Tuesday, November 1, 2022
Monday, October 31, 2022
- New Light on Key Differences in Immune Response to SARS-CoV-2 Vaccines
- New Insights on Antibody Responses to Omicron Variants
Wednesday, October 26, 2022
- Multistate Study Examines mRNA Vaccine Effectiveness for Immunocompromised Adults During Omicron BA.4 and BA.5 Predominance
- How Severe Is the SARS-CoV-2 Omicron BA.2 Subvariant Compared With Earlier Variants?
Monday, October 24, 2022
- Study Uncovers Mechanisms Necessary for SARS-CoV-2 Infection in Macrophages
- Intranasal COVID Vaccine That Works Against Variants in Animals
Wednesday, October 19, 2022
Tuesday, October 18, 2022
Thursday, October 13, 2022
Wednesday, October 12, 2022
Friday, October 7, 2022
Thursday, October 6, 2022
- Mouthwashes May Suppress SARS-CoV-2, Study Finds
- COVID-19: Boosting With an mRNA Vaccine Offers Better Protection in People Who Received Two Doses of CoronaVac
Tuesday, September 27, 2022
Friday, September 23, 2022
Wednesday, September 21, 2022
Wednesday, September 14, 2022
Friday, September 9, 2022
Thursday, September 1, 2022
Wednesday, August 31, 2022
Tuesday, August 30, 2022
Wednesday, August 17, 2022
- Most People Infected With Omicron Didn't Know It, Study Finds
- Gene Inhibitor Could Help Slow Thrombosis in COVID-19 Patients
Tuesday, August 9, 2022
- Universal Vaccine Needed to Prevent Future COVID-19 Waves, Study Suggests
- Increase in Non-COVID-19 Respiratory Infections Predicted This Winter
Monday, August 1, 2022
- The Lining of Children's Noses May Provide Protection from SARS-CoV-2 Infection
- Variant Type and Patient Sex Affect Molnupiravir Efficacy, Study Finds
Thursday, July 28, 2022
- New Needle-Free Nasal Vaccine Shows Promise for COVID-19
- COVID Vaccine Patch Fights Variants Better Than Needles, Study in Mice Shows
Wednesday, July 27, 2022
- Scientists Develop Effective Intranasal Mumps-Based COVID-19 Vaccine Candidate
- Promising Developments in Pursuit to Design Pan-Coronavirus Vaccine
Monday, July 25, 2022
- SARS-CoV-2 Variants Have Developed Resistance to Human Interferons, Study Finds
- A Third COVID-19 Booster Is Crucial to Identifying and Fighting New Variants, Study Finds
Friday, July 22, 2022
Thursday, July 21, 2022
- Your Body Remembers Common Cold Coronaviruses from Childhood. How Can You Get the Same Immunity to COVID-19?
- Protective T Cells Remain 20 Months After COVID-19, Study Finds
- Hypertension Elevates Risk for More Severe COVID-19 Illness
Tuesday, July 19, 2022
- Vaccine-Induced Immune Response to Omicron Wanes Substantially Over Time
- COVID-19 Transmission in Geriatric Acute Care Shows Need for Enhanced Infection Control and Prevention Measures
- Booster Shots Offset Some of Omicron Immune Evasion Tactics
- New Key Protection Against COVID-19 Found in Saliva
Monday, July 18, 2022
- Scientists Identify What Makes the Delta Variant Dangerous and Explain the Recent Surge in COVID-19 Infections
- Second mRNA Booster Significantly Effective Against Omicron Variants, Study Finds
Friday, July 15, 2022
Tuesday, July 12, 2022
Wednesday, July 6, 2022
Tuesday, July 5, 2022
- Inhalable COVID-19 Vaccine Shows Promise in Rodent Model
- Dominant Omicron Subvariants Better at Evading Vaccines, Antibody Treatments
Friday, July 1, 2022
Tuesday, June 28, 2022
Monday, June 27, 2022
- COVID-19 Omicron Variant Leads to Less Severe Disease in Mice, Study Finds
- The Surprising Link Between SARS-CoV-2 Infection and New-Onset Diabetes
Thursday, June 16, 2022
Wednesday, June 15, 2022
Tuesday, June 14, 2022
Wednesday, June 15, 2022
Wednesday, June 8, 2022
Friday, June 3, 2022
- COVID-19 Patient Antibodies Point Researchers Toward Broad Coronavirus Vaccines
- End of Strict COVID Measures in China Could Result in 1.5 Million Deaths, Study Finds
Tuesday, May 24, 2022
Thursday, May 19, 2022
Wednesday, May 18, 2022
Tuesday, May 17, 2022
Friday, May 13, 2022
Thursday, May 5, 2022
- Investigational COVID Mucosal Vaccine Protects Against Disease and Transmission
- How a COVID-19 Infection Spurs Antibodies Against Common Colds